First, Mon was found to play an anti‐tumor role in HCC cells by inhibiting cell proliferation and invasion, elevated the expression of E‐cadherin, and decreased N‐cadherin and Vimentin expression. The gene discussed is CDH2; the disease is hepatocellular carcinoma.